Justices Refuse to Hear ‘Skinny Label’ Drug Patent Case

May 15, 2023 by Dan McCue
Justices Refuse to Hear ‘Skinny Label’ Drug Patent Case
(Photo by Steve PB via Pixabay)

WASHINGTON — The Supreme Court on Monday declined to review a 2020 decision by the U.S. Circuit Court of Appeals for the Federal Circuit that resulted in Teva Pharmaceuticals being found liable for $235 million for infringing on a GlaxoSmithKline heart drug patent.

The case placed a spotlight on the use of so-called “skinny labels” for generic drugs, and justices refused to weigh in on the controversy despite a request from the U.S. solicitor general.

The underlying case began in 2014 when GlaxoSmithKline sued Teva Pharmaceuticals USA over its generic version of the Glaxo heart drug Coreg, a prescription medicine used to treat the symptoms of heart failure and high blood pressure.

Teva argued in court that it followed Food and Drug Administration instructions to “carve out” from its label a single use for the drug that would not infringe on any existing patent.

The “carve out” is a key provision of the Hatch-Waxman Act of the mid-1980s, whose drafters sought to create an innovative pathway to bring low-cost generic drugs to market.

When a brand-name drug has both patented and unpatented uses, its manufacturer must tell the FDA the specific sections of its labeling that describe the patented uses. 

That allows generic manufacturers to carve out those sections and adopt a “skinny label” — one labeled for only unpatented uses. 

Teva maintains it did just that. Nevertheless, in 2017, a jury awarded GlaxoSmithKline $235 million on its patent infringement claim.

A federal judge then overturned the verdict, but the U.S. Court of Appeals for the Federal Circuit, which specializes in patent cases, reinstated it in 2020, holding that the label, coupled with Teva’s marketing materials, did encourage doctors to prescribe its drug in a way that infringed on GlaxoSmithKline’s patent.

In its petition for a Supreme Court review of the case, Teva argued that the appeals court’s “controversial” opinion would “upend the legal rules facing the modern prescription-drug marketplace, wreaking doctrinal havoc.”

“Where there was previously clarity and ‘equilibrium to the skinny-label system,’ there is now confusion and uncertainty,” Teva said. “That uncertainty discourages generics from using carve-outs, which ‘throw[s] a wrench into Congress’ design for enabling quick public access to generic versions of unpatented drugs with unpatented uses.’” 

“The ramifications of such an outcome are enormous — skinny-label launches are extraordinarily common, and they save patients and the federal government billions,” it said.

Solicitor General Elizabeth Prelogar also urged the justices to hear the case, arguing the Federal Circuit’s decision created “significant uncertainty” for generic drugmakers.

As is their custom, the justices did not explain their rationale for rejecting the case. However, the court did note that Justice Brett Kavanaugh would have granted it a review.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • generic drugs
  • patent infringement
  • prescription drugs
  • skinny labels
  • Supreme Court
  • In The News

    Health

    Voting

    Supreme Court

    May 22, 2025
    by Tom Ramstack
    Supreme Court Lets Decision Stand Banning State-Funded Charter School

    WASHINGTON — The Supreme Court ruled Thursday that taxpayer money cannot be used to subsidize a religious-oriented charter school in... Read More

    WASHINGTON — The Supreme Court ruled Thursday that taxpayer money cannot be used to subsidize a religious-oriented charter school in Oklahoma. The split decision allows a lower court ruling to stand that said tax money for religious schools violates the establishment clause of the First Amendment.... Read More

    May 19, 2025
    by Dan McCue
    Supreme Court Allows Trump to Lift Deportation Protections for Venezuelans

    WASHINGTON — The Supreme Court on Monday said the Trump administration can proceed, for now, with its plan to toss... Read More

    WASHINGTON — The Supreme Court on Monday said the Trump administration can proceed, for now, with its plan to toss the Biden-era deportation protections of more than 300,000 Venezuelan immigrants. Nearly all of the justices approved the brief order in the ongoing case of Noem v.... Read More

    May 15, 2025
    by Dan McCue
    Justices Appear Divided Over Whether to Curb Nationwide Injunctions

    WASHINGTON — The Supreme Court appeared to be divided along ideological lines Thursday as it considered whether to remove the... Read More

    WASHINGTON — The Supreme Court appeared to be divided along ideological lines Thursday as it considered whether to remove the ability of lower court judges to issue nationwide injunctions. During a highly unusual oral argument this late in the term, the conservative justices seemed to believe... Read More

    May 15, 2025
    by Tom Ramstack
    Supreme Court Says Context of Police Shooting Determines Whether It’s Justified

    WASHINGTON — The Supreme Court appears to have made it easier for police officers to be sued for excessive use... Read More

    WASHINGTON — The Supreme Court appears to have made it easier for police officers to be sued for excessive use of force with a ruling Thursday that requires courts to consider the "totality of circumstances." The ruling resulted from the 2016 fatal shooting of a Houston,... Read More

    Former Supreme Court Justice David Souter, a Republican Who Became a Liberal Darling, Has Died

    WASHINGTON (AP) — Retired Supreme Court Justice David H. Souter, the ascetic bachelor and New Hampshire Republican who became a... Read More

    WASHINGTON (AP) — Retired Supreme Court Justice David H. Souter, the ascetic bachelor and New Hampshire Republican who became a darling of liberals during his nearly 20 years on the bench, has died. He was 85. Souter died Thursday at his home in New Hampshire, the court said... Read More

    May 6, 2025
    by Dan McCue
    Supreme Court Allows Transgender Ban in Military to Take Effect

    WASHINGTON — The Supreme Court on Tuesday said it will allow a Trump administration ban on transgender individuals serving in... Read More

    WASHINGTON — The Supreme Court on Tuesday said it will allow a Trump administration ban on transgender individuals serving in the military to take effect while legal proceedings on the matter continue. As is their custom when dealing with emergency applications, the justices gave no explanation... Read More

    News From The Well
    scroll top